Leonard Kirsch is an Ophthalmology physician. OpenAlex indexes 9 publications with 361 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
148 13th St SW
Largo, FL 337703127
Telephone
727-581-8706Registry record last updated 27 Apr 2018.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Harrow Eye, LLCProgram year20253 payments
- Apellis Pharmaceuticals, Inc.Program year20251 payment
- Dompe US, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
98%Antineovascularisation agents81.2%Faricimab-svoa99%Brolucizumab-dbll2%Part B, office-administered≥81 patientsComplement Inhibitor9.8%Avacincaptad pegol100%Part B, office-administered≥22 patients+ 8 more classes in this area
Cancer & immunology
1.1%Vascular Endothelial Growth Factor Inhibitor0.9%Aflibercept100%Part B, office-administered≥34 patientsCalcineurin inhibitor0.1%Restasis100%Part D<11 patientsMusculoskeletal
0.4%Cyclooxygenase Inhibitor0.4%Ketorolac Tromethamine100%Part D≥35 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase I/II Study of Intravitreal Cidofovir for the Treatment of Cytomegalovirus Retinitis in Patients With the Acquired Immunodeficiency Syndrome
American Journal of Ophthalmology
1995 - Local Treatment of Cytomegalovirus Retinitis in Patients with Acquired Immunodeficiency Syndrome
Seminars in Ophthalmology
1995
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”